Transient paroxysmal dystonia in an infant possibly induced by cisapride

被引:6
作者
Angelini, L [1 ]
Zorzi, G [1 ]
Rumi, V [1 ]
Nardocci, N [1 ]
Mennini, T [1 ]
机构
[1] IST RIC FARMACOL MARIO NEGRI, MILAN, ITALY
来源
ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES | 1996年 / 17卷 / 02期
关键词
transient paroxysmal dystonia; cisapride; drug induced movement disorder; infancy;
D O I
10.1007/BF02000848
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The case is reported of an infant presenting paroxysmal dystonia during cisapride theraphy. We suggest that this drug, a substituted benzamide, probably interfered with the age-related modification of striatal neurotransmitters, provoking extrapyramidal symptoms. Considering the widespread use of cisapride in early infancy for the treatment of gastrointestinal disorders, attention must be drawn to this possible side effect.
引用
收藏
页码:157 / 159
页数:3
相关论文
共 18 条
[1]   TRANSIENT PAROXYSMAL DYSTONIA IN INFANCY [J].
ANGELINI, L ;
RUMI, V ;
LAMPERTI, E ;
NARDOCCI, N .
NEUROPEDIATRICS, 1988, 19 (04) :171-174
[2]  
ANGELINI L, 1989, BAS GANGL 89 3 TRIEN, P7
[3]  
BENLOUCIF S, 1993, J PHARMACOL EXP THER, V265, P373
[4]   THE 5-HT4 RECEPTOR - A PLACE IN THE SUN [J].
BOCKAERT, J ;
FOZARD, JR ;
DUMUIS, A ;
CLARKE, DE .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (04) :141-145
[5]   DYSTONIC REACTIONS IN CHILDREN CAUSED BY METOCLOPRAMIDE [J].
CASTEELS.M ;
JAEKEN, J ;
VANDERSC.P ;
ZIMMERMA.A ;
VANDENBO.P .
ARCHIVES OF DISEASE IN CHILDHOOD, 1970, 45 (239) :130-&
[6]  
DAVSON H, 1972, STRUCTURE FUNCTION N, V4, P321
[7]   THE GASTROINTESTINAL PROKINETIC BENZAMIDE DERIVATIVES ARE AGONISTS AT THE NON-CLASSICAL 5-HT RECEPTOR (5-HT4) POSITIVELY COUPLED TO ADENYLATE-CYCLASE IN NEURONS [J].
DUMUIS, A ;
SEBBEN, M ;
BOCKAERT, J .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1989, 340 (04) :403-410
[8]   CHARACTERISTICS OF [C-14] GUANIDINIUM ACCUMULATION IN NG 108-15 CELLS EXPOSED TO SEROTONIN 5-HT3 RECEPTOR LIGANDS AND SUBSTANCE-P [J].
EMERIT, MB ;
RIAD, M ;
FATTACCINI, CM ;
HAMON, M .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (06) :2059-2067
[9]   RISK-FACTORS, CO-MEDICATION, AND CONCOMITANT DISEASES - THEIR INFLUENCE ON THE OUTCOME OF THERAPY WITH CISAPRIDE [J].
FEHR, HF .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 :40-46
[10]   SC-53116 - THE 1ST SELECTIVE AGONIST AT THE NEWLY IDENTIFIED SEROTONIN 5-HT(4) RECEPTOR SUBTYPE [J].
FLYNN, DL ;
ZABROWSKI, DL ;
BECKER, DP ;
NOSAL, R ;
VILLAMIL, CI ;
GULLIKSON, GW ;
MOUMMI, C ;
YANG, DC .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (08) :1486-1489